SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Clinical trials for SLL (SMALL LYMPHOCYTIC LYMPHOMA) explained in plain language.
Never miss a new study
Get alerted when new SLL (SMALL LYMPHOCYTIC LYMPHOMA) trials appear
Sign up with your email to follow new studies for SLL (SMALL LYMPHOCYTIC LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat blood cancers: rocbrutinib takes on pirtobrutinib in Head-to-Head trial
Disease control Recruiting nowThis study tests a new oral drug, rocbrutinib, against another drug, pirtobrutinib, in adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whose cancer has returned or not responded after prior treatment with a BTK inhibitor. About 306 participants …
Matched conditions: SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 26, 2026 11:22 UTC
-
New hope for hard-to-treat blood cancers: experimental drug enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called ZE50-0134 in about 66 adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or certain low-grade lymphomas that have returned or not responded to prior therapies. The main goals are to check the drug's safety and how …
Matched conditions: SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated May 18, 2026 12:11 UTC